We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Avalon Pharmaceuticals (MM) | NASDAQ:AVRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.59 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. 1)
Under the Securities
Exchange Act of 1934
Avalon Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
05346p106
(CUSIP Number)
December 31, 2008
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 05346p106
SCHEDULE 13G
Page 2 of 6 Pages
1
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Ironwood Investment Management, LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
1,154,674
6
SHARED VOTING POWER
0
7
SOLE DISPOSITIVE POWER
1,154,674
8
SHARED DISPOSITIVE POWER
0
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,154,674
10
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.7%
12
TYPE OF REPORTING PERSON
IA
CUSIP No. 05346p106
SCHEDULE 13G
Page 3 of 6 Pages
Item 1.
(a).
Name of Issuer: Avalon Pharmaceuticals, Inc.
(b).
Address of Issuer's Principal Executive Offices:
20358 Seneca Meadows Parkway
Germantown, MD 20876
Item 2.
(a).
Name of Person Filing:
Ironwood Investment Management, LLC | |||
(b).
Address of Principal Business Office or, if none, Residence:
Ironwood Investment Management, LLC
21 Custom House Street, Suite 240
Boston, MA 02110
(c).
Citizenship or Place of Organization: Massachusetts
Item 3. |
If this statement is filed pursuant to sections 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
||
(a) |
[ ] |
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); |
|
(b) |
[ ] |
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); |
|
(c) |
[ ] |
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); |
|
(d) |
[ ] |
Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); |
CUSIP No. 05346p106 |
SCHEDULE 13G |
Page 4 of 6 Pages |
(e)
An investment adviser in accordance with section 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with section 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with section 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
Group, in accordance with section 240.13d-1(b)(1)(ii)(J).
Item 4.
Ownership.
(a).
Amount beneficially owned:
(c). |
Number of shares as to which such person has: |
||
(1) |
Sole power to vote or to direct the vote: |
1,154,674 | ||
(2) |
Shared power to vote or to direct the vote: |
0 | ||
(3) | Sole power to dispose or to direct the disposition of: | 1,154,674 | ||
(4) | Shared power to dispose or to direct the disposition of: | 0 | ||
CUSIP No. 05346p106 |
SCHEDULE 13G |
Page 5 of 6 Pages |
Item 5.
Ownership of Five Percent or Less of a Class:
Not Applicable
Item 6.
Ownership of More Than Five Percent on Behalf of Another Person:
Not Applicable
Item 7.
Identification and Classification of Subsidiaries which Acquired the Security Being Reported on by the Parent Holding Company:
Not Applicable
Item 8.
Identification and Classification of Members of the Group:
Not Applicable
Item 9.
Notice of Dissolution of Group:
Not Applicable
Item 10. |
Certification: |
By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. | |
CUSIP No. 05346p106
SCHEDULE 13G
Page 6 of 6 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 13, 2009
1 Year Avalon Chart |
1 Month Avalon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions